National Research CORP Stock: price and directors' dealings · United States · SEC (Form 4)

About National Research CORP

National Research Corp. (NASDAQ: NRC), which operates under the NRC Health brand, is a U.S.-listed healthcare analytics and software company focused on measuring and improving the experiences of patients, consumers, employees, and care teams. For investors, the company should be viewed as a specialized healthcare technology provider rather than a broad-based software vendor. Its shares trade on the NASDAQ market in the United States, and the company is headquartered in Lincoln, Nebraska. ([sec.gov](https://www.sec.gov/Archives/edgar/data/70487/000100888625000093/ars.pdf)) Founded in 1981 by Michael D. Hays, NRC began as a research-oriented business and has evolved into a platform business built around “Human Understanding” and healthcare experience management. The company reports a single operating segment, with revenue derived primarily in the United States. Its business model is largely subscription-based, which supports recurring revenue visibility, although contract renewals remain an important factor to monitor. ([nrchealth.com](https://nrchealth.com/wp-content/uploads/2016/10/NRC2012AnnualReport-1.pdf)) NRC’s core solution stack is organized into four main categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience. These offerings combine surveys, digital feedback capture, analytics, benchmarking, reputation management, and decision-support tools for healthcare organizations. In practice, NRC helps hospitals, health systems, and other providers understand the full care journey and improve engagement, loyalty, compliance, and in some cases reimbursement under value-based care frameworks. Competitive differentiation comes from its healthcare-specific focus, an integrated experience-management platform, and long-standing customer relationships in a market where domain expertise and actionable insights matter as much as software functionality. ([sec.gov](https://www.sec.gov/Archives/edgar/data/70487/000100888625000093/ars.pdf)) Geographically, NRC is overwhelmingly U.S.-centric. The company stated that its 2024 revenue came primarily from the United States, while its Canadian operations were substantially liquidated, making Canada a non-material geography at this point. Its headquarters remains in Lincoln, Nebraska, with the company also renovating its main office building, underscoring a stable domestic operating base. ([sec.gov](https://www.sec.gov/Archives/edgar/data/70487/000100888625000093/ars.pdf)) Recent developments are important for market watchers. In March 2025, NRC announced that Trent Green would become CEO effective June 1, 2025, succeeding founder Michael Hays, who moved into the Chairman role. The company also released first-quarter 2025 results in April 2025 and continued to emphasize product innovation and healthcare partnership expansion. Recent customer wins and industry recognition, including awards in patient experience, suggest NRC is still actively competing for strategic accounts in its niche market. ([nrchealth.com](https://nrchealth.com/blog/nrc-health-appoints-trent-green-chief-executive-officer/?utm_source=openai))